Literature DB >> 19879426

Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.

Arturo Sala1, Saverio Bettuzzi, Sabina Pucci, Olesya Chayka, Michael Dews, Andrei Thomas-Tikhonenko.   

Abstract

In no other field has the function of clusterin (CLU) been more controversial than in cancer genetics. After more than 20 years of research, there is still uncertainty with regard to the role of CLU in human cancers. Some investigators believe CLU to be an oncogene, others-an inhibitor of tumorigenesis. However, owing to the recent efforts of several laboratories, the role of CLU in important cellular processes like proliferation, apoptosis, differentiation, and transformation is beginning to emerge. The "enigmatic" CLU is becoming less so. In this chapter, we will review the work of research teams interested in understanding how CLU is regulated by oncogenic signaling. We will discuss how and under what circumstances oncogenes and epigenetic factors modify CLU expression, with important consequences for mammalian tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879426      PMCID: PMC3426299          DOI: 10.1016/S0065-230X(09)05007-6

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  84 in total

1.  Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

Authors:  C R Yang; K Leskov; K Hosley-Eberlein; T Criswell; J J Pink; T J Kinsella; D A Boothman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells.

Authors:  Augusto Orlandi; Sabina Pucci; Alessandro Ciucci; Flavia Pichiorri; Amedeo Ferlosio; Luigi Giusto Spagnoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-09       Impact factor: 8.311

3.  Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.

Authors:  G Klock; S Storch; J Rickert; C Gutacker; C Koch-Brandt
Journal:  J Cell Physiol       Date:  1998-12       Impact factor: 6.384

4.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

5.  Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis.

Authors:  Valérie Devauchelle; Abdellatif Essabbani; Gonzague De Pinieux; Stéphane Germain; Léa Tourneur; Sylvie Mistou; Florence Margottin-Goguet; Philippe Anract; Henri Migaud; Dominique Le Nen; Thierry Lequerré; Alain Saraux; Maxime Dougados; Maxime Breban; Catherine Fournier; Gilles Chiocchia
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

6.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

8.  The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

Authors:  Andrea Caporali; Pierpaola Davalli; Serenella Astancolle; Domenico D'Arca; Maurizio Brausi; Saverio Bettuzzi; Arnaldo Corti
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

9.  Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis.

Authors:  O Takase; A W M Minto; T S Puri; P N Cunningham; A Jacob; M Hayashi; R J Quigg
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

Review 10.  Mornings with Art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses.

Authors:  Erik A Bey; Shelly M Wuerzberger-Davis; John J Pink; Chin-Rang Yang; Shinako Araki; Kathryn E Reinicke; Melissa S Bentle; Ying Dong; Eva Cataldo; Tracy L Criswell; Mark W Wagner; Longshan Li; Jinming Gao; David A Boothman
Journal:  J Cell Physiol       Date:  2006-12       Impact factor: 6.513

View more
  16 in total

1.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

2.  The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders.

Authors:  Chao Chen; Qingtuan Meng; Yan Xia; Chaodong Ding; Le Wang; Rujia Dai; Lijun Cheng; Preethi Gunaratne; Richard A Gibbs; Shishi Min; Cristian Coarfa; Jeffrey G Reid; Chunling Zhang; Chuan Jiao; Yi Jiang; Gina Giase; Amber Thomas; Dominic Fitzgerald; Tonya Brunetti; Annie Shieh; Cuihua Xia; Yongjun Wang; Yunpeng Wang; Judith A Badner; Elliot S Gershon; Kevin P White; Chunyu Liu
Journal:  Sci Transl Med       Date:  2018-12-13       Impact factor: 17.956

3.  Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.

Authors:  Jun You; Yuwen Han; Haifeng Qiao; Yun Han; Xiaoyan Lu; Yiling Lu; Xiaoyu Wang; Haili Kai; Yanli Zheng
Journal:  Aging (Albany NY)       Date:  2022-06-10       Impact factor: 5.955

4.  Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease.

Authors:  Liqin Zhao; Zisu Mao; Sarah K Woody; Roberta D Brinton
Journal:  Neurobiol Aging       Date:  2016-02-18       Impact factor: 4.673

5.  Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease.

Authors:  Ping Chen; Chao Wang; Xiaojie Ma; Yizhe Zhang; Qing Liu; Shi Qiu; Qiong Liu; Jing Tian; Jiazuan Ni
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60.

Authors:  K-A Chaiwatanasirikul; A Sala
Journal:  Cell Death Dis       Date:  2011-10-20       Impact factor: 8.469

7.  Genetics of clusterin isoform expression and Alzheimer's disease risk.

Authors:  I-Fang Ling; Jiraganya Bhongsatiern; James F Simpson; David W Fardo; Steven Estus
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.752

Review 8.  Calcium homeostasis and ER stress in control of autophagy in cancer cells.

Authors:  Elżbieta Kania; Beata Pająk; Arkadiusz Orzechowski
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

9.  Editorial: Targeting MYCN in Pediatric Cancers.

Authors:  Arturo Sala
Journal:  Front Oncol       Date:  2015-05-13       Impact factor: 6.244

10.  Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.

Authors:  Hans Prochnow; Rene Gollan; Philipp Rohne; Matthias Hassemer; Claudia Koch-Brandt; Markus Baiersdörfer
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.